logo
  1. Home
  2. Stocks
  3. Caplin Point Laboratories

Caplin Point Laboratories Share Price

Small Cap | Pharmaceuticals and health care | NSE: CAPLIPOINT | BSE: 524742

₹1,937.05 image-118.55 (-5.77 %)

Last Updated: 04 Apr 2025 03:57 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 2,059.95

High (₹) 2,069.75

Low (₹) 1,917.00

Prev. Close (₹) 2,055.60

Volume 1,10,853

VWAP (₹) 1,840.14

ROCE (%) 23.86

Industry P/E 44.73

TTM P/E 28.57

P/B Ratio 6.47

Market Cap (₹) Cr.14,723.85

Dividend Yield (%)0.26

EPS (₹) 59.90

ROE20.02%

Sales Growth (%) 15.50

Profit Growth (%)22.40

Day Range

2,069.752,069.75

L
H

52 Week Range

1,221.002,636.00

L
H

Historical Returns

Returns (6M)

0.52 %

Returns (1Y)

51.23 %

Returns (3Y)

147.58 %

Returns (5Y)

598.54 %

Returns (6M)

0.52 %

Returns (1Y)

51.23 %

Returns (3Y)

147.58 %

Returns (5Y)

598.54 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (21.80%) TTM EPS Growth
  • Company with no debt
  • Book value per share improving over the last 2 years
  • Company with 21.80% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 46.80

MFI 33.92

ATR 99.00

Commodity Channel Index -175.01

ROC125 1.56

ROC21 -10.26

Williams %R -96.18

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,889.711,956.931,998.761,847.881,780.661,738.831,671.61
Week Ago2,078.692,127.522,155.342,050.872,002.041,974.221,925.39
Month Ago1,947.891,996.822,078.241,866.471,817.541,736.121,687.19

EMA & SMA
info_icon

1937.05

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 1972.19

9 Day 1971.68

10 Day 1954.15

12 Day 1988.23

14 Day 2007.50

20 Day 2038.52

26 Day 2036.75

50 Day 2207.85

100 Day 2127.62

200 Day 1862.41

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GRAVITON RESEARCH CAPITAL LLPbulkSell26 Aug, 2024₹1,901.283,96,355NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy26 Aug, 2024₹1,899.603,96,355NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell19 Aug, 2024₹1,763.584,44,478NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy19 Aug, 2024₹1,761.724,44,478NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell09 Sept, 2021₹908.543,81,306NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy09 Sept, 2021₹908.193,81,306NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell27 Jul, 2021₹957.374,14,981NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy27 Jul, 2021₹957.624,14,981NSE
XTX MARKETS LLPbulkSell26 Jul, 2021₹910.584,60,816NSE
XTX MARKETS LLPbulkBuy26 Jul, 2021₹908.914,64,203NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
24 Mar, 2023P VijayalakshmiAcquisition₹609.008,98,790NSE
24 Nov, 2021Sathish KrishnanDisposal₹811.515,000NSE
24 Nov, 2021Arulsudar NatrajanDisposal₹831.001,500NSE
24 Nov, 2021Arulsudar NatrajanDisposal₹832.002,000NSE
19 Nov, 2021Arulsudar NatrajanDisposal₹866.051,500NSE
19 Nov, 2021Subramanian NarayanaswamyDisposal₹870.00100NSE
19 Nov, 2021Subramanian NarayanswamyDisposal₹867.754,900NSE
08 Nov, 2021Sachin Dondiram PatilAcquisition₹2.005,000NSE
08 Nov, 2021Rubavanan CAcquisition₹2.001,667NSE
08 Nov, 2021Venkataraju M PAcquisition₹2.002,500NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
07 Aug, 2024Rs.2.5000 per share(125%)Final Dividend23 Sept, 202401 Jan, 1970
16 May, 2024Rs.2.5000 per share(125%)Interim Dividend31 May, 202431 May, 2024
07 Aug, 2023Rs.2.5000 per share(125%)Final Dividend14 Sept, 202301 Jan, 1970

Announcements

DateSourceDetail
03 Apr, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
03 Apr, 2025BSE IndiaCompliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025 is enclosed.
02 Apr, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about General Updates that the Board of Directors of Caplin Point Far East Limited, Hong Kong, a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.
02 Apr, 2025BSE IndiaCaplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited, Hong Kong, a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.
29 Mar, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about Action(s) taken or orders passed. Enclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analyst s Meet/ Call held on August 30, 2024
29 Mar, 2025BSE IndiaEnclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analyst''s Meet/ Call on August 30, 2024.
25 Mar, 2025NSE IndiaCAPLIN POINT LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window
25 Mar, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
26 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 26, 2025, titled ""Press Release regarding receipt of USFDA Approval."".
14 Feb, 2025NSE IndiaCaplin Point Laboratories Limited has informed the Exchange about Transcript

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--01 Feb, 202507 Feb, 2025
Quarterly Results--31 Oct, 202407 Nov, 2024
Quarterly Results & Final Dividend--01 Aug, 202407 Aug, 2024
Audited Results & Interim Dividend--10 May, 202416 May, 2024
Quarterly Results--31 Jan, 202409 Feb, 2024
Quarterly Results--02 Nov, 202309 Nov, 2023
Quarterly Results, Final Dividend & A.G.M.--02 Aug, 202307 Aug, 2023
Audited Results & Interim Dividend(Revised)24 May, 202327 May, 2023
Audited Results & Interim Dividend--24 May, 202324 May, 2023
Quarterly Results--31 Jan, 202311 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group70.56%70.62%68.8%68.91%69.03%
Foreign Institutions +4.86%2.84%2.24%2.11%1.64%
Domestic Institutions +2.11%0.43%1.12%1.21%1.1%
Government0%0%0%0%0%
Public22.47%26.11%27.84%27.77%28.23%
Others0%0%0%0%0%

About Caplin Point Laboratories

Caplin Point Laboratories is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 625.09 Cr. and Equity Capital is Rs. 15.19 Cr. for the Year ended 31/03/2024.

Parent Organisation

Not Applicable

Founded

1990

Managing Director

Dr. Sridhar Ganesan

NSE Symbol

CAPLIPOINT

Caplin Point Laboratories Management

NameDesignation
Mr. C C PaarthipanChairman
Dr. Sridhar GanesanManaging Director
Dr. R NagendranIndependent Director
Mr. S DeenadayalanIndependent Director
Mr. D SathyanarayananIndependent Director
Dr. C K GariyaliIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Caplin Point Laboratories

What is the share price of Caplin Point Laboratories?

The share price of Caplin Point Laboratories on 04 Apr, 2025 is ₹ 1,937.05.

What is 52W high and 52W low share price of Caplin Point Laboratories?

The highest and lowest 52W share prices of Caplin Point Laboratories are ₹ 2636.000 and ₹ 1221.000

What is the market cap of Caplin Point Laboratories?

The market capitalization of Caplin Point Laboratories as of 04 Apr, 2025 is ₹ 14,723.85 Crores

What is the P/E ratio of Caplin Point Laboratories?

The current P/E ratio of Caplin Point Laboratories as of 04 Apr, 2025 is 44.73

What is the PB ratio of Caplin Point Laboratories?

The PB ratio of Caplin Point Laboratories as of 04 Apr, 2025 is 6.47

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited